• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CitiusTech Acquires SDLC Partners to Drive Health Plan Digital Transformation

Share:

June 29, 2021

What You Should Know:

– CitiusTech, a provider of healthcare technology services, solutions, and platforms, announced today the strategic acquisition of SDLC Partners (SDLC), a Pittsburgh, PA-based provider of technology solutions to leading payer organizations.

– As the need for value-based innovative technology solutions grows, combining SDLC’s expertise in payer-focused solutions with CitiusTech’s industry presence and rich portfolio of complementary digital offerings, CitiusTech will be uniquely positioned to drive digital transformation in the health plan industry.

Source: Hitconsultant

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence PlatformC2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform
  • How Intelligent Automation Can Address 3 Revenue Cycle ChallengesHow Intelligent Automation Can Address 3 Revenue Cycle Challenges
  • Avidity Science Acquires Edstrom Japan LtdAvidity Science Acquires Edstrom Japan Ltd
  • US Health Care Companies Begin Exploring Blockchain TechnologiesUS Health Care Companies Begin Exploring Blockchain Technologies
  • Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZenecaFortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca
  • Bicycle Health, Albertsons Partner to Boost Access to Opioid use Disorder InjectionsBicycle Health, Albertsons Partner to Boost Access to Opioid use Disorder Injections
  • Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology LaboratoriesQuest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
  • Vatic Antigen Test Achieves CE Mark StatusVatic Antigen Test Achieves CE Mark Status

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications